324 filings
Page 4 of 17
8-K
0vw4xnqxrjg503
10 May 21
PolarityTE Announces Diabetic Foot Ulcer Trial Met Primary and Secondary Endpoint
8:00am
8-K
nwb23ck557v3h
19 Apr 21
Departure of Directors or Certain Officers
4:30pm
8-K
vya88
30 Mar 21
PolarityTE Reports Fourth Quarter and Fiscal Year 2020 Results
7:00am
8-K
5h9k7i krwqh
9 Mar 21
Regulation FD Disclosure
7:00am
8-K
70b5viw0roil9o74
10 Feb 21
PolarityTE Provides Corporate Update
8:00am
8-K
4i0tgtg kk9uydo0
3 Feb 21
PolarityTE Receives Allowance for Additional U.S. Patent
5:25pm
8-K
6d9zrh cse1ti
27 Jan 21
Other Events
8:00am
8-K
wwgs ulmf4nzib
26 Jan 21
Entry into a Material Definitive Agreement
4:30pm
8-K
w22 zzcadsb
22 Jan 21
PolarityTE, Inc. Announces Exercise of Warrants for Gross Proceeds of $7.67 Million
8:55am
8-K
pc3yxwz74 v0bnm80rcw
21 Jan 21
PolarityTE Announces Completion of Target Enrollment in Diabetic Foot Ulcer Trial
8:00am
8-K
pjakbm1 nturplim32i
14 Jan 21
PolarityTE Announces Closing of $10.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
4:15pm
8-K
jiqo4 a5zb5
12 Jan 21
PolarityTE Announces $10.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
7:15am
8-K
k10 unpqa97vc2d
11 Jan 21
PolarityTE Announces Formation of Strategic Review Committee
8:15am
8-K
7m8r21allrus5kqdqzxy
23 Dec 20
Entry into a Material Definitive Agreement
4:05pm
8-K
2p8fx55drq5
22 Dec 20
PolarityTE Announces $8.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
8:15am
8-K
z6mh1zs5 xts2
11 Dec 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
qn92pzr xkj0
30 Nov 20
PolarityTE Receives Allowance for First U.S. Patent
8:00am
8-K
cyy51m 3gr16xm7d
23 Nov 20
Submission of Matters to a Vote of Security Holders
8:05am
8-K
1kohwbu
9 Nov 20
PolarityTE Reports Third Quarter 2020 Results
7:00am
8-K
bg7mhr690pu7i1je
2 Nov 20
PolarityTE Announces Successful Completion of Initial
8:01am